News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
671,978 Results
Type
Article (47288)
Company Profile (256)
Press Release (624434)
Multimedia
Podcasts (110)
Webinars (18)
Section
Business (189015)
Career Advice (2600)
Deals (34031)
Drug Delivery (121)
Drug Development (80979)
Employer Resources (158)
FDA (16182)
Job Trends (14818)
News (328615)
Policy (32417)
Tag
Academia (2774)
Academic (1)
Accelerated approval (11)
Adcomms (32)
Allergies (102)
Alliances (48618)
ALS (116)
Alzheimer's disease (1512)
Antibody-drug conjugate (ADC) (181)
Approvals (16154)
Artificial intelligence (358)
Autoimmune disease (35)
Automation (19)
Bankruptcy (341)
Best Places to Work (11540)
BIOSECURE Act (19)
Biosimilars (135)
Biotechnology (146)
Bladder cancer (97)
Brain cancer (39)
Breast cancer (371)
Cancer (2991)
Cardiovascular disease (238)
Career advice (2180)
Career pathing (34)
CAR-T (195)
CDC (30)
Cell therapy (526)
Cervical cancer (20)
Clinical research (66766)
Collaboration (1075)
Company closure (3)
Compensation (536)
Complete response letters (32)
COVID-19 (2679)
CRISPR (66)
C-suite (352)
Cystic fibrosis (110)
Data (3031)
Decentralized trials (2)
Denatured (32)
Depression (73)
Diabetes (362)
Diagnostics (6400)
Digital health (22)
Diversity (8)
Diversity, equity & inclusion (42)
Drug discovery (150)
Drug pricing (147)
Drug shortages (35)
Duchenne muscular dystrophy (131)
Earnings (72327)
Editorial (45)
Employer branding (20)
Employer resources (143)
Events (102933)
Executive appointments (904)
FDA (17854)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (971)
Gene editing (141)
Generative AI (29)
Gene therapy (412)
GLP-1 (883)
Government (4653)
Grass and pollen (5)
Guidances (180)
Healthcare (18420)
HIV (42)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (177)
Immuno-oncology (11)
Indications (40)
Infectious disease (2865)
Inflammatory bowel disease (150)
Inflation Reduction Act (12)
Influenza (66)
Intellectual property (124)
Interviews (532)
IPO (15285)
IRA (53)
Job creations (3697)
Job search strategy (1795)
Kidney cancer (15)
Labor market (41)
Layoffs (527)
Leadership (26)
Legal (7521)
Liver cancer (80)
Longevity (10)
Lung cancer (426)
Lymphoma (212)
Machine learning (11)
Management (55)
Manufacturing (416)
MASH (99)
Medical device (13169)
Medtech (13174)
Mergers & acquisitions (19464)
Metabolic disorders (923)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (40)
Neuroscience (2243)
NextGen: Class of 2025 (6456)
Non-profit (4499)
Now hiring (42)
Obesity (473)
Opinion (272)
Ovarian cancer (103)
Pain (119)
Pancreatic cancer (123)
Parkinson's disease (195)
Partnered (22)
Patents (313)
Patient recruitment (172)
Peanut (51)
People (58707)
Pharmaceutical (95)
Pharmacy benefit managers (25)
Phase I (20662)
Phase II (29356)
Phase III (22140)
Pipeline (1677)
Policy (229)
Postmarket research (2591)
Preclinical (8584)
Press Release (70)
Prostate cancer (146)
Psychedelics (45)
Radiopharmaceuticals (267)
Rare diseases (499)
Real estate (5728)
Recruiting (65)
Regulatory (22866)
Reports (34)
Research institute (2453)
Resumes & cover letters (387)
Rett syndrome (10)
RNA editing (8)
RSV (51)
Schizophrenia (96)
Series A (167)
Series B (113)
Service/supplier (15)
Sickle cell disease (65)
Special edition (21)
Spinal muscular atrophy (152)
Sponsored (32)
Startups (3507)
State (2)
Stomach cancer (16)
Supply chain (83)
Tariffs (64)
The Weekly (76)
Vaccines (798)
Venture capital (54)
Weight loss (311)
Women's health (42)
Worklife (19)
Date
Today (80)
Last 7 days (359)
Last 30 days (1842)
Last 365 days (31162)
2025 (16961)
2024 (35033)
2023 (39370)
2022 (50124)
2021 (54411)
2020 (53066)
2019 (46640)
2018 (35364)
2017 (32522)
2016 (31724)
2015 (36761)
2014 (29341)
2013 (24433)
2012 (26158)
2011 (26785)
2010 (24231)
Location
Africa (861)
Alabama (62)
Alaska (7)
Arizona (190)
Arkansas (13)
Asia (42080)
Australia (7511)
California (7009)
Canada (2353)
China (710)
Colorado (322)
Connecticut (297)
Delaware (198)
Europe (92084)
Florida (1106)
Georgia (245)
Hawaii (1)
Idaho (54)
Illinois (654)
India (29)
Indiana (373)
Iowa (17)
Japan (236)
Kansas (97)
Kentucky (31)
Louisiana (16)
Maine (62)
Maryland (1014)
Massachusetts (5281)
Michigan (249)
Minnesota (452)
Mississippi (3)
Missouri (88)
Montana (28)
Nebraska (23)
Nevada (82)
New Hampshire (71)
New Jersey (2084)
New Mexico (29)
New York (2072)
North Carolina (1097)
North Dakota (10)
Northern California (3023)
Ohio (230)
Oklahoma (14)
Oregon (38)
Pennsylvania (1545)
Puerto Rico (18)
Rhode Island (36)
South America (1196)
South Carolina (35)
South Dakota (1)
Southern California (2666)
Tennessee (123)
Texas (1095)
United States (26737)
Utah (219)
Virginia (191)
Washington D.C. (74)
Washington State (610)
West Virginia (4)
Wisconsin (80)
671,978 Results for "innovation pharma formerly known as cellceutix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Europe
With Tariffs Looming, EU and US Pharmas Make Demands of European Commission
Playing both sides of trade war, pharma companies are asking for certain compensations for scientific innovation and a smoother regulatory framework.
April 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Hengrui Pharma Showcases Global Impact at the 2025 ASCO: 72 Study Results Highlight Chinese Cancer Innovation
June 5, 2025
·
3 min read
Press Releases
UroGen Pharma to Present at TD Cowen: 6th Annual Oncology Innovation Summit: Insights for ASCO & EHA
May 27, 2025
·
1 min read
Press Releases
Innovent Announces NMPA Approval of Limertinib, a Third-generation EGFR TKI Collaborated with ASK Pharma, for the First-line Treatment of Lung Cancer
April 28, 2025
·
7 min read
Press Releases
Onco-Innovations Announces Start of Manufacturing of Preclinical Testing Material for Its PNKP Inhibitor Technology by Dalton Pharma
May 27, 2025
·
6 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Deals
Revolution Establishes Endless Cash Runway With $2B Royalty Pharma Deal
In May, Revolution Medicines projected its cash and equivalents of $2.1 billion would last into the second half of 2027. With new funding from Royalty Pharma, the biotech has withdrawn that runway end date.
June 24, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
April 18, 2025
·
6 min read
Press Releases
Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025
March 26, 2025
·
7 min read
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
1 of 67,198
Next
